Patients who quit smoking and took an aspirin and statin before blocked leg arteries treatment were less likely to suffer complications, U.S. researchers say. Lead study author Dr. P. Michael Grossman, an interventional cardiologist at the University of Michigan Cardiovascular Center, said peripheral arterial disease is on the rise as people age and conditions such as diabetes, high blood pressure and obesity affect circulation. Peripheral vascular interventions, such as angioplasty, improve blood flow, specifically to the legs. The study, published online ahead of print in Circulation: Cardiovascular Interventions, found but before peripheral vascular interventions more than half of patients studied failed to receive minimal medical therapy, meaning that the patient quit smoking and took an aspirin and a statin -- drugs which reduce the risk of blood clots and improve blood flow. Even the doctors treating the patients for their blockages didn't always ensure that their patients went home from the hospital with a prescription, Grossman said. At admission, 46.7 of patients were on aspirin, a statin and did not smoke; at discharge 71 percent were on both drugs and either did not smoke or still smoked but had smoking cessation counseling, Grossman said. "The modest improvement in statin prescription before patients were discharged signifies a missed opportunity to provide a life-saving intervention for peripheral arterial disease patients," Grossman said in a statement.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor